CytoVeris develops optical-based probes enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery.
CytoVeris's investors include Connecticut Innovations, MedTech Innovator, Cycle Venture Partners, Cycle Ventures.
CytoVeris is headquartered in Farmington, United States.
CytoVeris develops optical-based probes enabling surgical oncologists to identify and remove tumor tissue during cancer resection surgery.
CytoVeris is at the Non-equity Assistance stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"CytoVeris — Funding & Investors." VCBacked, May 29, 2024, https://www.vcbacked.co/company/cytoveris. Accessed September 30, 2026.
VCBacked. (2024). CytoVeris — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/cytoveris
{{cite web |title=CytoVeris — Funding & Investors |url=https://www.vcbacked.co/company/cytoveris |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated